Clinical Trial Update: Docetaxel and Vinorelbine Plus Filgrastim in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

This is a Phase 2 clinical trial evaluating the combination of docetaxel and vinorelbine plus filgrastim in patients with stage IIIB or stage IV non-small cell …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Navelbine (vinorelbine)
• Neupogen (Filgrastim)
• Taxotere (docetaxel)

Snippet

Sponsor: Amgen | Conditions: Lung Cancer | Phase 2 | Status: UNKNOWN